Stablix

Protein Stabilization Therapeutics

New York, United States · Founded 2021 · $63.0M raised

Headquarters
New York, New York
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$63.0M
Last Round
$63.0M Series AJun 2021
Rounds
1

About

Stablix has a first-in-category platform that can restore protein stability and function in a target-selective manner, addressing an important therapeutic white space for numerous devastating diseases. The company is initially leveraging the platform to develop programs to treat rare diseases, cancer and immunological disorders. Targeted Protein Stabilization can be thought of as the inverse of protein degradation, a concept that has been validated in nature.

Summary

Stablix is a Biotech company based in New York, United States, founded in 2021. It has raised $63.0M in total across 1 round, most recently a $63.0M Series A round in Jun 2021. Investors include Versant Ventures, New Enterprise Associates and Access Industries.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2021
$63.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Stablix on Indexed.vc
<a href="https://indexed.vc/companies/stablix"><img src="https://indexed.vc/api/badge/company/stablix" alt="Stablix on Indexed.vc" width="260" height="76" /></a>